EGFRvIII promotes the expression of the low‐density lipoprotein receptor (LDLR) through a PI3K/AKT/SREBP‐1‐dependent pathway both in vitro in U87 GBM cells and in vivo using subcutaneous xenografts from human primary GBM cells [99]. This evidence concerns the gene AKT1 and glioblastoma.